FULC

Conviction 18HealthcareScan · Mon, Aug 10, 2026

FULC$3.76-3.47%

ResistanceSupportVol 14Insider buyInsider sell

Vol MA14 1.55M

May 11May 28Jun 16Jul 6Jul 23Aug 10

Fulcrum Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.fulcrumtx.com ↗

Price3.76

Change-3.47%

Gap-1.41%

Rel volume1.92×

Avg volume1.57M

Avg $ vol5.77M

SMA 203.69

SMA 503.76

SMA 2007.79

Price vs 50+0.00%

Price vs 200-51.80%

MA stackbearish

50/200 cross—

Supertrenddown · 4.17

RSI (14)48

MACD hist0.05

MACD cross—

Stoch %K / %D65 / 81

ADX (14)16

+DI / −DI15 / 17

RSI divergence—

MACD divergence—

ATR %+4.91%

ADR %4.49%

52w high14.60

52w low3.14

From 52w high-74.28%

Above 52w low+19.59%

New 52w highNo

SqueezeOn · 22d

Bollinger width9.85%

%B0.67

Donchian pos66.30%

Donchian high3.91

Donchian low3.45

AVWAP (52w high)6.67

vs AVWAP high-43.72%

AVWAP (52w low)3.49

vs AVWAP low+7.53%

OBV trendFlat

Chaikin MF (20)0.04

Today vs 20d1.92×

Avg vol (14d)1.55M

Avg vol (20d)1.57M

Avg $ vol (20d)5.77M

Market cap—

RS 3m (vs SPY)-49.16%

RS 6m (vs SPY)-73.38%

RS line new highNo

Trend template0/8

Technical rank23.1

1 week+1.21%

1 month+7.29%

3 months-46.43%

6 months-61.45%

1 year-44.86%

YTD-65.61%

P/E-3.96

P/B0.96

P/S—

P/FCF-4.92

EPS-1.18

Div yield—

ROE-24.10%

ROA-23.11%

Debt/Eq—

Current31.35

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-669.97%

Price target3.43

Target upside-11.83%

Analyst ratingHold

Institutional102.36%

Ent. value248.33M

Revenue7.8M

Net income-26.18M

Gross profit—

Free cash flow-60.38M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out66.63M

Employees55

ListedThu, Jul 18, 2019

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction18 / 100

Pattern quality—

Tech rank23.1 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance3.97

Support3.42

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in FULC

All disclosures →

No recent disclosed trades by Congress in FULC. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in FULC · 5 buys · 1 sell

Insider	Side	Shares	Value	Traded	Filed
TANG KEVIN 10% owner · Common Stock · 2026-07-15	Buy	107.38K	$382K	2026-07-15	2026-07-15
TANG KEVIN 10% owner · Common Stock · 2026-07-14	Buy	53.65K	$191K	2026-07-14	2026-07-15
TANG KEVIN 10% owner · Common Stock · 2026-07-14	Buy	75.95K	$272K	2026-07-14	2026-07-15
TANG KEVIN 10% owner · Common Stock · 2026-07-13	Buy	12.97K	$46K	2026-07-13	2026-07-15
Ezekowitz Alan Director · Common Stock · 2026-06-26	Sell	18K	$66K	2026-06-26	2026-06-30
Lehrer-Graiwer Joshua Director · Stock Option (right to buy) · 2026-04-23	Grant	64K	$0	2026-04-23	2026-05-01

SEC filings

EDGAR filings in FULC · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.